Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders

NCT00008307 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: melphalan
DRUG: methylprednisolone
DRUG: mycophenolate mofetil
PROCEDURE: allogeneic bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
PROCEDURE: syngeneic bone marrow transplantation

Sponsor

Herbert Irving Comprehensive Cancer Center

Collaborators

[object Object]